title: Effects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation.
abstract: BACKGROUND
  Allografts from older donors may be more immunogenic than those from younger donors. Pretransplantation cellular sensitization may interact with advanced donor age to increase the risk of immune injury after deceased-donor kidney transplantation.
  
  
  METHODS
  The outcomes of 118 consecutive deceased-donor kidney transplant recipients with available pretransplantation donor-stimulated enzyme-linked immunosorbent spot (ELISPOT) assays for interferon gamma were analyzed retrospectively to determine the impact of cellular sensitization and other clinical variables, including donor age, on the incidence of acute rejection (AR) in the first year after deceased-donor transplantation and on estimated glomerular filtration rate 12 months after transplantation.
  
  
  RESULTS
  The incidence of AR was higher in patients with positive pretransplantation ELISPOT assays versus those with negative assays (36% vs. 14%, P=0.009). Logistic regression indicated that the combination of donor age 50 years or older and a positive pretransplantation ELISPOT assay was more strongly associated with AR (odds ratio, 12.1; confidence interval, 1.1-133) than either variable alone. Estimated glomerular filtration 12 months after transplantation was highest in ELISPOT-negative patients receiving kidneys from donors younger than 50 years and lowest in ELISPOT-positive recipients with donors 50 years or older.
  
  
  CONCLUSIONS
  The combination of advanced donor age and pretransplantation cellular sensitization increases the risk of AR and poor graft function after deceased-donor kidney transplantation beyond the risk associated with each factor alone.
authors.affiliation: Division of Nephrology, Department of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. dhricik@aol.com
authors.forename: Donald E
authors.initials: DE
authors.lastname: Hricik
authors.forename: Emilio D
authors.initials: ED
authors.lastname: Poggio
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Woodside
authors.forename: Naragaju
authors.initials: N
authors.lastname: Sarabu
authors.forename: Edmund Q
authors.initials: EQ
authors.lastname: Sanchez
authors.forename: James A
authors.initials: JA
authors.lastname: Schulak
authors.forename: Aparna
authors.initials: A
authors.lastname: Padiyar
authors.forename: Peter S
authors.initials: PS
authors.lastname: Heeger
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Augustine
mesh_terms: D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D058501:Enzyme-Linked Immunospot Assay; D005260:Female; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000209:etiology*; D006801:Humans; D007371:Interferon-gamma / Q000032:analysis; D016030:Kidney Transplantation / Q000009:adverse effects*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D014019:Tissue Donors
chemical_list: D007371:Interferon-gamma